Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page
- Check2 days agoChange DetectedThe study page continues to display a 403 Forbidden error instead of study information.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays a 403 Forbidden error page with minimal HTML, replacing the previous detailed study content and locations.SummaryDifference17%

- Check38 days agoChange DetectedNIH grant/contract funding information (2017) was added to the study's identifiers, clarifying funding and registry references. The page's revision label was updated to v3.6.6.SummaryDifference0.1%

- Check59 days agoChange DetectedThe footer now shows Revision: v3.6.5, replacing v3.6.4, indicating a recent software update to the page.SummaryDifference0.0%

- Check73 days agoChange DetectedFooter revision tag updated to Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor page update rather than a change to study content.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.6.3 was added, replacing the previous Revision: v3.6.2. This indicates a page version update rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.